Harpoon Therapeutics, Inc. (HARP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 24.08M |
| Enterprise Value | -11.53M |
| P/E Ratio | -1.14 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 27.11 |
| Price/Book Ratio | 14.14 |
| Enterprise/Revenue | 25.99 |
| Enterprise/EBITDA | -12.57 |
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | September 30, 2023 |
| Profit Margin | -2.1 |
| Operating Margin | -2.14 |
| Return On Assets | -0.91 |
| Return On Equity | -2.12 |
| Revenue | 31.92M |
| Revenue/Share | 9.62 |
| Gross Profit | 28.82M |
| EBITDA | -65.97M |
| Net Income | -67.14M |
| Diluted EPS | -20.24 |
| Total Cash | 31.61M |
| Total Cash/Share | 16.01 |
| Total Debt | 14.5M |
| Total Debt/Equity | 2.96 |
| Current Ratio | 1.04 |
| Book Value Per Share | 1.63 |
| 52-Week Change | 257.3 |
| 52-Week High | 23.21 |
| 52-Week Low | 3.11 |
| Moving Average 50 Days | 20.73 |
| Moving Average 200 Days | 10.76 |
| Average Volume | 1.13M |
| Shares Outstanding | 37.6M |
| % Held by Institutions | 47.09 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | September 05, 2023 |